Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H. and Vehreschild, J. J. (2019). Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin. Microbiol. Infect., 25 (10). S. 1200 - 1213. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691

Full text not available from this repository.

Abstract

Objectives: Candidaemia is a serious hazard to hospitalized patients, but European epidemiological data are restricted to national studies focusing on Northern Europe, population-based surveillance programmes or studies conducted in distinct local areas. The aim was to provide current data on the overall burden and epidemiological development of candidaemia in Europe. Methods: A Web of Knowledge T search was carried out from January 2000 to February 2019. Appropriate data were collected on total cases, study duration, incidence, species distribution and/or mortality rates. Meta-analysis was performed to pool individual studies. Heterogeneity was examined using the I-2 statistic. Calculations of pooled incidence and mortality rates, subgroup analysis by geographical origin, study period and scenarios were carried out. Daily candidaemia incidence and mortality rates in Europe were extrapolated. Systematic review and meta-analysis were used to determine incidence and mortality of candidaemia in the UN European region. Complete datasets were categorized into population-based and hospital-based epidemiological studies and were analysed separately. Subgroup analyses were performed for geographic distributions and time-dependent developments. Results: In population-based studies, 43 799 cases of candidaemia were diagnosed in 1 885 271 885 person-years, revealing an overall pooled incidence rate of 3.88/100 000. The highest pooled incidence rate was observed in intensive care units ( 5.5/1000 admissions, Day 30 mortality rate 37%), followed by tertiary care centres ( 0.96/1000 admissions, pooled Day 30 mortality rate 38%) and the mixed group of teaching and general hospitals ( 0.52/1000 admissions, pooled Day 30 mortality rate 37%). European incidence of candidaemia was extrapolated to approximately 79 cases per day, of which an estimated 29 patients might have fatal outcome at Day 30. Conclusions: Pooled incidence rates, species distribution and outcome of candidaemia differ considerably between clinical groups, European regions and over time. We observed an increasing overall pooled incidence rate of candidaemia and a higher proportion of Candida spp. other than C. albicans in the current decade in population-based data. (c) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Koehler, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stecher, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cornely, O. A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koehler, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vehreschild, M. J. G. T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bohlius, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wisplinghoff, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vehreschild, J. J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-133070
DOI: 10.1016/j.cmi.2019.04.024
Journal or Publication Title: Clin. Microbiol. Infect.
Volume: 25
Number: 10
Page Range: S. 1200 - 1213
Date: 2019
Publisher: ELSEVIER SCI LTD
Place of Publication: OXFORD
ISSN: 1469-0691
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; INVASIVE FUNGAL-INFECTIONS; CRITICALLY-ILL PATIENTS; NON-NEUTROPENIC PATIENTS; POPULATION-BASED SURVEILLANCE; ANTIFUNGAL DRUG-RESISTANCE; ESCMID-ASTERISK GUIDELINE; TERTIARY REFERRAL CENTER; RISK-FACTORSMultiple languages
Infectious Diseases; MicrobiologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/13307

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item